Found: 121
Select item for more details and to access through your institution.
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort.
- Published in:
- Rare Tumors, 2024, p. 1, doi. 10.1177/20363613241271669
- By:
- Publication type:
- Article
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1707, doi. 10.3390/cancers16091707
- By:
- Publication type:
- Article
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1763, doi. 10.3390/cancers16091763
- By:
- Publication type:
- Article
The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol.
- Published in:
- Neurosurgical Focus, 2024, v. 56, n. 5, p. 1, doi. 10.3171/2024.2.FOCUS2416
- By:
- Publication type:
- Article
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 904, doi. 10.3390/cancers16050904
- By:
- Publication type:
- Article
Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2023, v. 12, n. 5, p. 792, doi. 10.1089/jayao.2022.0179
- By:
- Publication type:
- Article
Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 4, p. 4282, doi. 10.1002/cam4.5298
- By:
- Publication type:
- Article
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30874-8
- By:
- Publication type:
- Article
Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2022, v. 11, n. 3, p. 328, doi. 10.1089/jayao.2021.0103
- By:
- Publication type:
- Article
An updated review of the treatment landscape for advanced gastrointestinal stromal tumors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 11, p. 3565, doi. 10.1002/cam4.3903
- By:
- Publication type:
- Article
A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 3037, doi. 10.2147/OTT.S291801
- By:
- Publication type:
- Article
Outcomes of systemic therapy in metastatic phyllodes tumor of the breast.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 186, n. 3, p. 871, doi. 10.1007/s10549-021-06116-8
- By:
- Publication type:
- Article
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 8, p. 1301, doi. 10.1002/cncr.33349
- By:
- Publication type:
- Article
Real‐world outcomes of patients with locally advanced or metastatic epithelioid sarcoma.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 8, p. 1311, doi. 10.1002/cncr.33365
- By:
- Publication type:
- Article
Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e639, doi. 10.1002/onco.13674
- By:
- Publication type:
- Article
Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 250, doi. 10.1002/onco.13616
- By:
- Publication type:
- Article
Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2927, doi. 10.3390/cancers12102927
- By:
- Publication type:
- Article
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1768, doi. 10.3390/cancers12071768
- By:
- Publication type:
- Article
PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma.
- Published in:
- Sarcoma, 2020, p. 1, doi. 10.1155/2020/8363986
- By:
- Publication type:
- Article
Immuno-genomic landscape of osteosarcoma.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14646-w
- By:
- Publication type:
- Article
Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Corrigendum to “SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy”.
- Published in:
- Sarcoma, 2019, p. 1, doi. 10.1155/2019/7608743
- By:
- Publication type:
- Article
Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.
- Published in:
- 2019
- By:
- Publication type:
- journal article
MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 677, doi. 10.3390/cancers11050677
- By:
- Publication type:
- Article
Outcome of First‐Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 110, doi. 10.1634/theoncologist.2017-0574
- By:
- Publication type:
- Article
SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy.
- Published in:
- Sarcoma, 2018, p. 1, doi. 10.1155/2018/2068517
- By:
- Publication type:
- Article
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The challenge of the management of adolescents and young adults with soft tissue sarcomas.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor.
- Published in:
- Oncologist, 2018, v. 23, n. 3, p. 360, doi. 10.1634/theoncologist.2017-0408
- By:
- Publication type:
- Article
Primary Osteosarcoma in the Elderly Revisited: Current Concepts in Diagnosis and Treatment.
- Published in:
- Current Oncology Reports, 2018, v. 20, n. 2, p. 1, doi. 10.1007/s11912-018-0658-1
- By:
- Publication type:
- Article
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.
- Published in:
- Oncologist, 2018, v. 23, n. 1, p. 62, doi. 10.1634/theoncologist.2017-0161
- By:
- Publication type:
- Article
The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 12, p. 1, doi. 10.1007/s11912-017-0641-2
- By:
- Publication type:
- Article
Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults.
- Published in:
- Oncologist, 2017, v. 22, n. 10, p. 1271, doi. 10.1634/theoncologist.2016-0464
- By:
- Publication type:
- Article
Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion.
- Published in:
- Sarcoma, 2017, p. 1, doi. 10.1155/2017/7495914
- By:
- Publication type:
- Article
Clinical trial enrollment of adolescents and young adults with sarcoma.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 18, p. 3434, doi. 10.1002/cncr.30757
- By:
- Publication type:
- Article
Systematic Review of the Outcomes of Surgical Treatment of Prostate Metastases to the Spine.
- Published in:
- Global Spine Journal, 2017, v. 7, n. 5, p. 460, doi. 10.1177/2192568217710911
- By:
- Publication type:
- Article
Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 12, p. 3437, doi. 10.1002/cam4.956
- By:
- Publication type:
- Article
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies.
- Published in:
- Scientific Reports, 2016, p. 35448, doi. 10.1038/srep35448
- By:
- Publication type:
- Article
Chemotherapy for soft tissue sarcoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
An Unusual Case of Central Retinal Vein Occlusion and Review of the Toxicity Profile of Regorafenib in GIST Patients.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 8, p. 1, doi. 10.1007/s11912-016-0536-7
- By:
- Publication type:
- Article
Assessing the role of F-FDG PET and F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 5, p. 860, doi. 10.1007/s00259-015-3242-z
- By:
- Publication type:
- Article
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-015-0160-2
- By:
- Publication type:
- Article
Chemotherapy for Soft-Tissue Sarcomas.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 1, p. 43
- By:
- Publication type:
- Article